Dementia update 2005MORRIS, John C.Alzheimer disease and associated disorders. 2005, Vol 19, Num 2, pp 100-117, issn 0893-0341, 18 p.Article

How do you approach the problem of TSH elevation in a patient on high-dose thyroid hormone replacement?MORRIS, John C.Clinical endocrinology (Oxford. Print). 2009, Vol 70, Num 5, pp 671-673, issn 0300-0664, 3 p.Article

Pharmacokinetic rationale for switching from donepezil to galantamineMAELICKE, Alfred.Clinical therapeutics. 2001, Vol 23, pp A8-A12, issn 0149-2918, SUPAArticle

Pharmacokinetic profiles of current therapies for alzheimer's disease: Implications for switching to galantamineFARLOW, Martin R.Clinical therapeutics. 2001, Vol 23, pp A13-A24, issn 0149-2918, SUPAArticle

The nosology of dementiaMORRIS, John C.Neurologic clinics. 2000, Vol 18, Num 4, issn 0733-8619, v, 773-788 [17 p.]Article

The potential of functional MRI as a biomarker in early Alzheimer's diseaseSPERLING, Reisa.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S37-S43, SUP1Article

Adrenal hemorrhage : A 25-year experience at the Mayo ClinicVELLA, Adrian; NIPPOLDT, Todd B; MORRIS, John C et al.Mayo Clinic proceedings. 2001, Vol 76, Num 2, pp 161-168, issn 0025-6196Article

Evidence that age-associated memory impairment is not a normal variant of agingGOLDMAN, William P; MORRIS, John C.Alzheimer disease and associated disorders. 2001, Vol 15, Num 2, pp 72-79, issn 0893-0341Article

Interobserver disagreements on Clinical Dementia Rating assessment: Interpretation and implications for trainingTRACTENBERG, Rochelle E; SCHAFER, Kimberly; MORRIS, John C et al.Alzheimer disease and associated disorders. 2001, Vol 15, Num 3, pp 155-161, issn 0893-0341Article

Switching previous therapies for Alzheimer's disease to galantamineFERRIS, Steven H.Clinical therapeutics. 2001, Vol 23, pp A3-A7, issn 0149-2918, SUPAArticle

Advances in interleukin 2 receptor targeted treatmentMORRIS, John C; WALDMANN, Thomas A.Annals of the rheumatic diseases. 2000, Vol 59, pp i109-i114, issn 0003-4967, SUP1Article

Lung cancer-initiating cells: a novel target for cancer therapyMORRISON, Brian J; MORRIS, John C; STEEL, Jason C et al.Targeted oncology. 2013, Vol 8, Num 3, pp 159-172, issn 1776-2596, 14 p.Article

Cognitive Decline and Brain Volume Loss as Signatures of Cerebral Amyloid-β Peptide Deposition Identified With Pittsburgh Compound B: Cognitive Decline Associated With Aβ DepositionSTORANDT, Martha; MINTUN, Mark A; HEAD, Denise et al.Archives of neurology (Chicago). 2009, Vol 66, Num 12, pp 1476-1481, issn 0003-9942, 6 p.Article

Accelerated weight loss may precede diagnosis in Alzheimer diseaseJOHNSON, David K; WILKINS, Consuelo H; MORRIS, John C et al.Archives of neurology (Chicago). 2006, Vol 63, Num 9, pp 1312-1317, issn 0003-9942, 6 p.Article

Antecedent biomarkers of Alzheimer's disease : The adult children studyCOATS, Mary; MORRIS, John C.Journal of geriatric psychiatry and neurology. 2005, Vol 18, Num 4, pp 242-244, issn 0891-9887, 3 p.Article

CSF biomarkers for Alzheimer's disease: current utility and potential future useHOLTZMAN, David M.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S4-S9, SUP1Article

Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer's disease-modifying treatmentsREIMAN, Eric M.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S44-S47, SUP1Article

Personality traits distinguishing dementia with Lewy bodies from Alzheimer diseaseGALVIN, James E; MALCOM, Heather; JOHNSON, David et al.Neurology. 2007, Vol 68, Num 22, pp 1895-1901, issn 0028-3878, 7 p.Article

The value of informant versus individual's complaints of memory impairment in early dementiaCARR, David B; GRAY, Steven; BATY, Jack et al.Neurology. 2000, Vol 55, Num 11, pp 1724-1726, issn 0028-3878Article

Thyroid cancer: zealous imaging has increased detection and treatment of low risk tumoursBRITO, Juan P; MORRIS, John C; MONTORI, Victor M et al.BMJ (Overseas and retired doctors ed.). 2013, Vol 347, Num 7923, pp 18-21, issn 1759-2151, 4 p.Article

Blood-based biomarkers for Alzheimer's disease: plasma Aβ40 and Aβ42, and genetic variantsMAYEUX, Richard; SCHUPF, Nicole.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S10-S19, SUP1Article

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementiaKLUNK, William E.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S20-S36, SUP1Article

Alliance for Aging Research AD Biomarkers Work Group: structural MRIJACK, Clifford R.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S48-S57, SUP1Article

Changes in cognitionALBERT, Marilyn S.Neurobiology of aging. 2011, Vol 32, issn 0197-4580, S58-S63, SUP1Article

Thyrotropin-axis adaptation in aging and chronic diseaseSTAN, Marius; MORRIS, John C.Endocrinology and metabolism clinics of North America. 2005, Vol 34, Num 4, issn 0889-8529, x, 973-992 [21 p.]Article